Guidelines Issued for Primary Biliary Cholangitis Care
Clinical guidelines for managing primary biliary cholangitis were published in the November issue of Gastroenterology and Hepatology.
Updated on Nov. 2, 2026 in Cancer

The American Gastroenterological Association and the American Association for the Study of Liver Diseases issued clinical guidelines for managing primary biliary cholangitis. The guidelines were published in the November issue of Gastroenterology and Hepatology.
Why it matters
The guidelines give clinicians a consensus framework for managing primary biliary cholangitis, a chronic liver condition. The panel's recommendations were built on a structured review of the evidence.
The guideline panel reviewed evidence for six prioritized clinical questions and agreed on six recommendations. The source does not detail the specific recommendations or the quality of evidence behind each one.
The players
Cynthia Levy, M.D.
Hepatologist at the University of Miami Miller School of Medicine who led development of the guidelines.
American Gastroenterological Association
Professional society of gastroenterologists that co-issued the guidelines.
American Association for the Study of Liver Diseases
Professional society focused on liver disease research and care that co-issued the guidelines.
The details
Cynthia Levy, M.D., of the University of Miami Miller School of Medicine led development of the guidelines. Several authors disclosed ties to the pharmaceutical industry.
Timeline
November 2026: Guidelines published in the November issue of Gastroenterology and Hepatology.
Health Landscape
Joint guidelines from the American Gastroenterological Association and the American Association for the Study of Liver Diseases extend the consensus-based guideline process both societies use for hepatology care. The publication reflects ongoing efforts to standardize management of chronic liver disease across U.S. practice.
Patients with primary biliary cholangitis and their clinicians can use these guidelines to inform treatment discussions. The extraction does not specify how the recommendations change day-to-day management or access to care.
The takeaway
Consensus guidelines give patients and clinicians a shared reference for managing a chronic liver condition. Staying aware of updated recommendations can help people with the condition discuss their care with their doctors.
Further reading
Explore more on Cancer coverage across the United States.










